The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meetings of their kind across the globe since 2000. From basic research to commercial manufacture, this one meeting covers the whole vaccine value chain where science, government and manufacturers all come together […]
The American Biomanufacturing Summit is one of the most senior-level biomanufacturing conferences and networking events in the industry. Our executive biomanufacturing event is designed to provide biopharma executives with current trends, strategic insights and best practices in manufacturing, outsourcing, capacity management, quality assurance, quality control, regulatory compliance, operational excellence, supply chain and logistics.
From groundbreaking presentations to dynamic panel discussions and expert-led roundtables, this event offers you invaluable insights into the challenges and opportunities across the gene therapy landscape. Whether it’s overcoming clinical trial complexities, navigating evolving regulatory requirements, or optimizing manufacturing scalability, this summit equips you with the knowledge needed to mitigate risks, avoid costly setbacks, and accelerate your gene […]
Press Release: Avid Bioservices Announces Grand Opening of New Early Phase Center of Excellence in Costa Mesa, California Costa Mesa, Calif. – [February 24, 2026] – Avid Bioservices, Inc., a dedicated biologics CDMO, today announced the grand […]
Seasoned business and finance leader brings growth mindset to support Avid’s next phase expansion and client execution TUSTIN, Calif. — [January 15, 2026] — Avid Bioservices, a leading contract development […]
The newly created role marks a major step in CEO Kenneth Bilenberg’s vision to scale Avid for its next chapter of growth. TUSTIN, Calif., November 10, 2025 – Avid […]
Tustin, CA, USA – September 15, 2025 – Avid Bioservices, Inc., a leading biologics contract development and manufacturing organization (CDMO), today announced the appointment of Kenneth Bilenberg as its new […]
SOUTH SAN FRANCISCO, California – August 05, 2025 – Privately held CHO Plus, Inc. announced today a project agreement awarded from the Biomedical Advanced Research and Development Authority’s (BARDA) Biopharmaceutical […]